FULPHILA Solution for injection Ref.[9539] Active ingredients: Pegfilgrastim

Source: European Medicines Agency (EU)  Revision Year: 2020  Publisher: Mylan S.A.S., 117 allรฉe des Parcs, 69800, Saint-Priest, France

Product name and form

Fulphila 6 mg solution for injection in pre-filled syringe.

Pharmaceutical Form

Solution for injection (injection).

Clear, colourless solution for injection.

Qualitative and quantitative composition

Each pre-filled syringe contains 6 mg of pegfilgrastim* in 0.6 mL solution for injection. The concentration is 10 mg/mL based on protein only**.

* Produced in Escherichia coli cells by recombinant DNA technology followed by conjugation with polyethylene glycol (PEG).
** The concentration is 20 mg/mL if the PEG moiety is included.

The potency of this product should not be compared to the potency of another pegylated or non-pegylated protein of the same therapeutic class. For more information, see section 5.1

Excipient with known effect: Each pre-filled syringe contains 30 mg sorbitol (E420).

For the full list of excipients, see section 6.1.

Active Ingredient Description
Pegfilgrastim

Pegfilgrastim is a sustained duration form of filgrastim due to decreased renal clearance. Pegfilgrastim and filgrastim have been shown to have identical modes of action, causing a marked increase in peripheral blood neutrophil counts within 24 hours, with minor increases in monocytes and/or lymphocytes.

List of Excipients

Sodium acetate*
Sorbitol (E420)
Polysorbate 20
Water for injections

* Sodium acetate is formed by titrating glacial acetic acid with sodium hydroxide.

Pack sizes and marketing

Pre-filled syringe (Type I glass), with a fluorotec-coated bromobutyl rubber stopper and a stainless steel needle with or without an automatic needle guard.

Pack size of one pre-filled syringe, in blistered packaging.

Marketing authorization holder

Mylan S.A.S., 117 allรฉe des Parcs, 69800, Saint-Priest, France

Marketing authorization dates and numbers

EU/1/18/1329/001 1 pre-filled syringe
EU/1/18/1329/002 1 pre-filled syringe with needle guard

Date of first authorisation: 20 November 2018

Drugs

Drug Countries
FULPHILA Austria, Australia, Brazil, Canada, Estonia, Finland, France, Hong Kong, Croatia, Ireland, Israel, Lithuania, New Zealand, Poland, Romania, United States

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.